TPG, a US-based private equity firm, has completed the acquisition of Optum UK from UnitedHealth Group in a transaction valued at approximately $400 million. Optum UK operates EMIS, a software platform that manages electronic health records for millions of NHS patients across more than half of England’s general practitioner practices, making it one of the most critical technology providers in the National Health Service’s primary care infrastructure.
The transaction has prompted widespread criticism from medical professionals, patient advocates, and lawmakers who argue that the transfer occurred with insufficient public transparency and democratic oversight. Representatives from Doctors’ Association UK characterized the development as problematic, noting that the records of over half the country’s population now sit on a system controlled by an investment firm prioritizing investor returns rather than patient care. Liberal Democrat health spokesperson Helen Morgan called for enhanced scrutiny of similar deals and advocated for greater investment in British technology companies.
Additional concerns stem from TPG’s international healthcare operations. An investigation conducted earlier this year by the International Consortium of Investigative Journalists examined hospitals in Kenya owned by Evercare, a healthcare organization backed by TPG’s Rise Fund. The investigation documented allegations that patients incurred substantial debts and, in certain instances, were required to pledge property deeds as security for unpaid medical expenses. Anna Marriott, a former health policy official, characterized the acquisition as deeply troubling given TPG’s contested track record in healthcare internationally and the minimal public scrutiny accompanying the transaction.
TPG and EMIS have responded by asserting that data protection standards remain unchanged following the ownership transfer. They emphasized that all existing legal, regulatory, contractual, and operational safeguards continue to apply to patient information. According to their statements, the acquisition underwent review and received approval through government channels under the National Security and Investment Act 2021. TPG stated that it cannot access, control, maintain, or utilize NHS patient records and remains committed to strengthening data protection standards.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI